|
Hypertension and diabetes
|
|
Number of participants in group
|
2732
|
6.314
|
9.046
|
|
Number of NHAs (% of individuals in the group)
|
1018 (37.3%)
|
1507 (23.9%)
|
2525 (27.9%)
|
|
Quarters until NHA, mean (SD)
|
8.0 (7.4)
|
11.6 (9.3)
|
10.1 (8.8)
|
|
Hypertension and depression
|
|
Number of participants in group
|
1231
|
2006
|
3237
|
|
Number of NHAs (% of individuals in the group)
|
482 (39.1%)
|
556 (27.7%)
|
1038 (32.1%)
|
|
Quarters until NHA, mean (SD)
|
8.9 (8.7)
|
13.5 (11.1)
|
11.4 (10.3)
|
|
Hypertension and COPD
|
|
Number of participants in group
|
586
|
1656
|
2242
|
|
Number of NHAs (% of individuals in the group)
|
175 (29.9%)
|
319 (19.3%)
|
494 (22.0%)
|
|
Quarters until NHA, mean (SD)
|
8.1 (7.9)
|
11.8 (10.3)
|
10.5 (9.7)
|
|
Hypertension and diabetes and depression
|
|
Number of participants in group
|
734
|
1136
|
1870
|
|
Number of NHAs (% of individuals in the group)
|
277 (37.7%)
|
320 (28.2%)
|
597 (31.9%)
|
|
Quarters until NHA, mean (SD)
|
8.2 (8.3)
|
11.9 (10.0)
|
10.2 (9.4)
|
|
Hypertension and diabetes and COPD
|
|
Number of participants in group
|
348
|
1098
|
1446
|
|
Number of NHAs (% of individuals in the group)
|
96 (27.6%)
|
184 (16.8%)
|
280 (19.4%)
|
|
Quarters until NHA, mean (SD)
|
7.9 (6.5)
|
10.5 (9.0)
|
9.6 (8.3)
|
|
Hypertension and diabetes and heart failure
|
|
Number of participants in group
|
245
|
627
|
872
|
|
Number of NHAs (% of individuals in the group)
|
72 (29.4%)
|
124 (19.8%)
|
196 (22.5%)
|
|
Quarters until NHA, mean (SD)
|
8.3 (7.4)
|
9.6 (8.1)
|
9.1 (7.8)
|
